US Patent Issued to Case Western Reserve University, The Cleveland Clinic Foundation on May 12 for "Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)" (Ohio Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. RE50,888, issued on May 12, was assigned to Case Western Reserve University (Cleveland) and The Cleveland Clinic Foundation (Cleveland).

"Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)" was invented by Anant Madabhushi (Shaker Heights, Ohio), Xiangxue Wang (Cleveland Heights, Ohio), Cristian Barrera (Cleveland) and Vamsidhar Velcheti (Pepper Pike, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments access a digitized image of tissue demonstrating non-small cell lung cancer (NSCLC), the tissue including a plurality of c...